Aditi Ahlawat, MD
Neurology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 11 years
- University of Massachusetts Medical School, 2015
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahlawat’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$55,124
Medicare paid this office $55,124 for 270 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 143 | $24,062 | $129 |
| New patient visit (60+ min) | 83 | $12,565 | $150 |
| Muscle electrical test | 55 | $2,491 | $27 |
| Return visit (30+ min) | 17 | $1,877 | $110 |
| Nerve test | 33 | $1,810 | $55 |
See all 7 services
| Long return visit (40+ min) | 143 | $24,062 | $129 |
| New patient visit (60+ min) | 83 | $12,565 | $150 |
| Muscle electrical test | 55 | $2,491 | $27 |
| Return visit (30+ min) | 17 | $1,877 | $110 |
| Nerve test | 33 | $1,810 | $55 |
| Nerve test | 22 | $1,585 | $72 |
| Muscle electrical test | 14 | $360 | $13 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
270 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 14% · Women 61% · Also on Medicaid 13% · Health risk score 1.21. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 68% · Coronary heart disease 27% · Depression 26% · Chronic kidney disease 20% · Cancer 20% · Atrial fibrillation 20% · Diabetes 17% · Stroke 17% · Dementia 14% · Heart failure 12% · COPD 7%.
The office billed $343,563, Medicare allowed $84,819 and paid $55,124; for 2,103 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 270 | 2,103 | 77 | 1.21 | $343,563 | $55,124 |
| 2023 | 281 | 1,073 | 76 | 1.08 | $359,649 | $66,257 |
| 2022 | 408 | 4,409 | 74 | 1.56 | $341,539 | $93,173 |
| 2021 | 342 | 1,236 | 74 | 1.54 | $290,622 | $81,076 |
| 2020 | 70 | 107 | 74 | 1.36 | $44,337 | $12,450 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| New patient visit (60+ min) | 83 | $16,003 | $193 |
| Long return visit (40+ min) | 67 | $12,881 | $159 |
| New patient visit (45+ min) | 72 | $10,479 | $146 |
| Return visit (30+ min) | 71 | $9,817 | $114 |
| Muscle electrical test | 68 | $4,433 | $39 |
| Nerve test | 54 | $3,656 | $68 |
| Nerve test | 25 | $2,248 | $90 |
| Muscle electrical test | 39 | $1,075 | $15 |
| Nerve test | 16 | $904 | $56 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 12 | $143 | $11 |
2022: 12 services
| Return visit (30+ min) | 150 | $19,734 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 102 | $11,055 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $6,651 | $81 |
| New patient visit (45+ min) | 49 | $5,709 | $117 |
| Nerve test | 62 | $5,353 | $86 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $4,339 | $94 |
| Muscle electrical test | 83 | $4,316 | $37 |
| Long return visit (40+ min) | 22 | $3,844 | $148 |
| Nerve test | 18 | $1,962 | $109 |
| Nerve test | 25 | $1,572 | $63 |
| Muscle electrical test | 61 | $1,341 | $15 |
| Nerve test | 13 | $711 | $55 |
2021: 14 services
| Return visit (30+ min) | 120 | $21,377 | $101 |
| New patient visit (45+ min) | 89 | $10,459 | $118 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $10,274 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $8,231 | $85 |
| Long return visit (40+ min) | 26 | $4,063 | $145 |
| Nerve test | 33 | $3,672 | $111 |
| Nerve test | 25 | $3,328 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,162 | $158 |
| New patient visit (60+ min) | 20 | $3,136 | $157 |
| Muscle electrical test | 77 | $3,026 | $38 |
| Nerve test | 15 | $2,364 | $158 |
| Nerve test | 26 | $2,330 | $90 |
| Muscle electrical test | 57 | $1,076 | $16 |
| Nerve test | 11 | $733 | $67 |
2020: 3 services
| New patient visit (45+ min) | 26 | $3,440 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,008 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,926 | $88 |
Medicaid work
$2,783 in 2024
Medicaid paid $2,783 for 28 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 28 | $2,783 |
| 2024 | 28 | 1 | 13 | $2,783 |
| 2023 | 26 | 1 | 13 | $2,559 |
| 2022 | 37 | 1 | 13 | $2,274 |
| 2021 | 24 | 1 | 12 | $1,664 |
See the largest Medicaid services in earlier years
2023
| New patient visit (60+ min) | 26 | $2,559 |
2022
| Return visit (30+ min) | 37 | $2,274 |
2021
| Return visit (30+ min) | 24 | $1,664 |
Drugs they prescribed that Part D paid
$98,957
Pharmacies billed $98,957 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (14 of 489) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
430 generic and 59 brand-name prescriptions · $98,957 in drug cost · 36 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nurtec Odt | None | 13 | $13,362 | $1,028 |
| Aimovig | Migraine | 17 | $12,411 | $730 |
| Ajovy | None | 14 | $9,856 | $704 |
| Mycophenolate Mofetil | None | 24 | $1,135 | $47 |
| Gabapentin | None | 96 | $1,032 | $11 |
See all 14 drugs
| Nurtec Odt | None | 13 | $13,362 | $1,028 |
| Aimovig | Migraine | 17 | $12,411 | $730 |
| Ajovy | None | 14 | $9,856 | $704 |
| Mycophenolate Mofetil | None | 24 | $1,135 | $47 |
| Gabapentin | None | 96 | $1,032 | $11 |
| Donepezil | None | 78 | $791 | $10 |
| Levetiracetam | None | 11 | $460 | $42 |
| Carbidopa-Levodopa | None | 21 | $355 | $17 |
| Lamotrigine | None | 29 | $322 | $11 |
| Quetiapine | None | 31 | $272 | $9 |
| Escitalopram | None | 14 | $224 | $16 |
| Clopidogrel | None | 12 | $168 | $14 |
| Prednisone | None | 17 | $155 | $9 |
| Tramadol | None | 14 | $84 | $6 |
Year by year
| 2024 | 489 | 117 | 3% (14) | 12% | $98,957 |
| 2023 | 386 | 141 | None | 8% | $109,427 |
| 2022 | 724 | 139 | None | 8% | $233,247 |
| 2021 | 525 | 101 | 2% (12) | 7% | $153,753 |
| 2020 | 206 | 55 | None | None | $10,071 |
| 2019 | 171 | 54 | None | None | $13,877 |
| 2018 | 61 | 27 | 0% (0) | None | $1,996 |
| 2017 | 67 | 21 | None | 31% | $11,725 |
| 2016 | 69 | 34 | None | 33% | $7,869 |
| 2015 | 41 | 21 | None | None | $2,207 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Gabapentin | 94 | $2,104 | $22 |
| Mycophenolate Mofetil | 18 | $1,377 | $77 |
| Quetiapine | 19 | $483 | $25 |
| Donepezil | 33 | $307 | $9 |
| Prednisone | 27 | $182 | $7 |
| Lamotrigine | 16 | $86 | $5 |
2022: 14 drugs
| Ingrezza | 25 | $188,875 | $7,555 |
| Mycophenolate Mofetil | 39 | $7,501 | $192 |
| Brilinta | 15 | $5,320 | $355 |
| Gabapentin | 219 | $3,531 | $16 |
| Quetiapine | 24 | $1,101 | $46 |
| Pregabalin | 13 | $1,087 | $84 |
| Baclofen | 21 | $978 | $47 |
| Methylphenidate | 11 | $915 | $83 |
| Donepezil | 58 | $800 | $14 |
| Escitalopram | 26 | $453 | $17 |
| Prednisone | 47 | $444 | $9 |
| Levetiracetam | 17 | $386 | $23 |
| Lamotrigine | 19 | $264 | $14 |
| Nortriptyline | 16 | $162 | $10 |
2021: 10 drugs
| Ingrezza | 11 | $80,374 | $7,307 |
| Brilinta | 15 | $4,353 | $290 |
| Gabapentin | 164 | $2,415 | $15 |
| Mycophenolate Mofetil | 20 | $2,176 | $109 |
| Quetiapine | 14 | $1,323 | $94 |
| Donepezil | 47 | $498 | $11 |
| Baclofen | 13 | $308 | $24 |
| Prednisone | 24 | $268 | $11 |
| Atorvastatin | 13 | $179 | $14 |
| Metoprolol | 11 | $33 | $3 |
2020: 5 drugs
| Mycophenolate Mofetil | 32 | $3,745 | $117 |
| Pyridostigmine | 12 | $1,001 | $83 |
| Azathioprine | 11 | $737 | $67 |
| Prednisone | 64 | $680 | $11 |
| Gabapentin | 14 | $148 | $11 |
2019: 3 drugs
| Mycophenolate Mofetil | 13 | $1,403 | $108 |
| Propranolol Hcl Er | 11 | $561 | $51 |
| Prednisone | 30 | $556 | $19 |
2018: 3 drugs
| Levetiracetam | 11 | $347 | $32 |
| Atorvastatin | 12 | $210 | $18 |
| Gabapentin | 11 | $195 | $18 |
Money from drug and device companies
$814 in 2025
| 2025 | 14 | 21 | None | $814 |
| 2024 | 2 | 2 | None | $33 |
| 2023 | 2 | 2 | None | $46 |
| 2022 | 8 | 24 | $1,125 | $2,500 |
| 2021 | 8 | 38 | $13 | $591 |
| 2020 | 2 | 3 | None | $87 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | None | $150 | 1 payment
|
| Biotronik Nro | Prospera | $142 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $138 | 4 payments
|
| Abbvie | Botox | $85 | 3 payments
|
| Axsome Therapeutics | Symbravo | $47 | 2 payments
|
| SK Life Science | None | $46 | 2 payments
|
See all 21 published payments
| Jazz Pharmaceuticals | Meals · 2025-12-11 | Epidiolex | $20 |
| Alexion Pharmaceuticals | Meals · 2025-11-19 | Ultomiris | $33 |
| SK Life Science | Meals · 2025-10-23 | None | $27 |
| Abbvie | Meals · 2025-10-09 | Botox | $30 |
| Axsome Therapeutics | Meals · 2025-09-30 | Symbravo | $32 |
| Pfizer | Meals · 2025-09-23 | Nurtec Odt | $29 |
| Grifols USA | Meals · 2025-09-19 | Gamunex-C | $27 |
| Neurocrine BioSciences | Meals · 2025-09-17 | Ingrezza | $28 |
| Argenx US | Meals · 2025-08-18 | Vyvgart | $26 |
| Noctrix Health | Meals · 2025-08-13 | Nidra | $22 |
| Abbvie | Meals · 2025-08-06 | Botox | $34 |
| Alexion Pharmaceuticals | Meals · 2025-08-01 | Ultomiris | $23 |
| Axsome Therapeutics | Meals · 2025-07-23 | Sunosi | $15 |
| Abbvie | Meals · 2025-07-15 | Botox | $21 |
| SK Life Science | Meals · 2025-07-02 | None | $20 |
| Resmed | Meals · 2025-06-18 | Airsense | $27 |
| Biotronik Nro | Meals · 2025-05-27 | Prospera | $142 |
| Alexion Pharmaceuticals | Meals · 2025-04-08 | Ultomiris | $54 |
| Ucb | Meals · 2025-04-07 | None | $150 |
| Alexion Pharmaceuticals | Meals · 2025-04-02 | Ultomiris | $28 |
| Eisai | Meals · 2025-03-13 | Leqembi | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $33
| Abbvie | Botox | $17 | 1 payment
|
| Otsuka America Pharmaceutical | Nuedexta | $16 | 1 payment
|
2023: $46
| AbbVie | Botox | $28 | 1 payment
|
| Argenx US | Vyvgart Hytrulo | $18 | 1 payment
|
2022: $2,500
| Argenx US | Vyvgart | $1,938 | 4 payments
|
| Abbvie | Qulipta | $208 | 9 payments
|
| Teva Pharmaceuticals USA | Austedo | $165 | 3 payments
|
| SK Life Science | None | $62 | 2 payments
|
| Allergan | Botox | $45 | 2 payments
|
| MDD US Operations | Xadago | $44 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $22 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $17 | 1 payment
|
2021: $591
| Allergan | Botox | $161 | 10 payments
|
| AbbVie | Ubrelvy | $122 | 14 payments
|
| SK Life Science | None | $94 | 4 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $78 | 4 payments
|
| Amgen | Aimovig | $56 | 2 payments
|
| Alnylam Pharmaceuticals | Onpattro | $47 | 2 payments
|
| Neurelis | Valtoco | $20 | 1 payment
|
| Acorda Therapeutics | Inbrija | $13 | 1 payment
|
2020: $87
| Neurelis | Valtoco | $62 | 2 payments
|
| Biogen | Vumerity | $26 | 1 payment
|
Professional record
- NPI
- 1104207901
- Licence
- MA 278348
- Trained
- University of Massachusetts Medical School, 2015 · 11 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 3 Harbor Dr Ste 111, Sausalito, CA, 94965
- NPI first listed
- 2015-06-17
- NPI last updated
- 2026-06-05
- NPI record certified
- 2026-06-05
This is when the NPI record was last certified, not a medical board exam.